Estimates Revisions Imugene Limited

Stocks

Market Closed - Australian S.E. 02:10:10 2026-08-14 EDT			5-day change	1st Jan Change
0.0820 ^AUD	-1.20%		-2.38%	-77.53%

07-01	Imugene Says Additional Patient in BTKi Group of Azer-Cel Phase 1b Study Achieves Complete Response, Shares Surge 26%	MT
05-25	Imugene Limited Announces Appointment of Charmaine Gittleson and Michael Kotsanis as Non-Executive Directors, Effective June 30, 2026	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	1y. EPS revision
IMUGENE LIMITED	-
LONZA GROUP AG
REVOLUTION MEDICINES, INC.
BEONE MEDICINES AG
IQVIA HOLDINGS INC.
CELLTRION, INC.
ASCENDIS PHARMA A/S		-
MEDPACE HOLDINGS, INC.
EUROFINS SCIENTIFIC SE
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Average
Weighted average by Cap.